Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and ...

I was going through the classic clinical leadership route, doing a lot of work regionally and some advisory work ...

A U.S. Army soldier is participating in a clinical trial at Walter Reed testing a neural-enabled prosthetic limb designed to ...

Beena Wood, Qinecsa, saw 2025 as an AI superposition in which pharmacovigilence needed better data foundations and regulation ...

Tom Coffey OBE. Senior Health Adviser to the Mayor of London, UK. At this year’s Global Innovation and New Technology (GIANT) ...

This interview is the second extended discussion between Professor Reiss and the World Socialist Web Site examining the ...

The Food and Drug Administration (FDA) updated its guidance on Tuesday to allow more wearables to fall into a general ...

A study of 27,670 Swedish participants suggests the role of dietary fats—including saturated fats from certain foods—in brain ...

Faster thinning of cpRNFL and mGCIPL is associated with visual field progression in glaucoma, with rates of –1.02 and –1.04 ...

As the year comes to a close, the Trump administration seems to be going in two different directions when it comes to the use ...

Englewood Health — operator of one of the remaining independent hospitals in New Jersey — has signed an agreement with RWJ ...

Pharmaceutical Separation Science Session Day two of HPLC 2025 concluded with a session on pharmaceutical separations chaired ...